Wednesday, August 19, 2020 1:59:18 PM
Amateur 17... This IS good news for Patients.. Was discussing Covid Rx in ICU’s with my batchmate in Florida last evening.. He’s incharge of the ICU.. and has basically 2 Entire floors given to him..besides his 22 Bed ICU..to accommodate the overflow of patient’s...!!!
The Change in Protocol ..To having EVERY Serious / Critical patient receiving..IV steroids.. Dexamethasone 6mg daily..Remdesivir.. Toclizumab..Anticoagulants..Followed by CONVALESCENT Plasma..Has reduced the death rate to 15% from the 60% they were having just 3 months ago..However taking out Toclizumab and Plasma may not hurt the survival rate..in my opinion..
Delayed intubation of patient’s with Oxygen Saturation of 88-92 %..Instead using BiPaP... Proning..(Laying the patients on their bellies).. AND the EARLY use of Potent Steroids is in MY opinion responsible for this turnaround..
If you now ADD.. Leronlimab.. GAME OVER..!!!!
IMHO
The Change in Protocol ..To having EVERY Serious / Critical patient receiving..IV steroids.. Dexamethasone 6mg daily..Remdesivir.. Toclizumab..Anticoagulants..Followed by CONVALESCENT Plasma..Has reduced the death rate to 15% from the 60% they were having just 3 months ago..However taking out Toclizumab and Plasma may not hurt the survival rate..in my opinion..
Delayed intubation of patient’s with Oxygen Saturation of 88-92 %..Instead using BiPaP... Proning..(Laying the patients on their bellies).. AND the EARLY use of Potent Steroids is in MY opinion responsible for this turnaround..
If you now ADD.. Leronlimab.. GAME OVER..!!!!
IMHO
Recent CYDY News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/21/2026 04:15:12 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/20/2026 09:08:39 PM
- CytoDyn to Present at the LD Micro Invitational XVI • GlobeNewswire Inc. • 05/15/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
